Company / Net Debt per Share
LIFECORE BIOMEDICAL, INC. \DE\ Net Debt per Share History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$3.40
FY2019
5-year range
$1.07 / $3.40
FY2015-FY2019
Trend
+157.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share returned to growth in FY2019 after 2 years of decline, reaching $3.40.
Based on SEC 10-K filings.
3.40 in FY2019 with a 5-year CAGR of +49.0%.
Increased from $1.46 to $3.40 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- +31.4%
- 5-Year CAGR
- +49.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, net debt per share increased 157.3% year-over-year.
- Lowest net debt per share in the period was in FY2014.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $3.40 | +157.3% |
| FY2018 | $1.32 | -9.5% |
| FY2017 | $1.46 | -2.6% |
| FY2016 | $1.50 | +39.4% |
| FY2015 | $1.07 | +132.5% |
| FY2014 | $0.46 | -5.1% |
| FY2013 | $0.49 | +3.0% |
| FY2012 | $0.47 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026